These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17062991)

  • 1. Effect of gefitinib on brain metastases from non-small cell lung cancer.
    Nishi N; Kawai S; Yonezawa T; Fujimoto K; Masui K
    Neurol Med Chir (Tokyo); 2006 Oct; 46(10):504-7. PubMed ID: 17062991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer.
    Hotta K; Kiura K; Ueoka H; Tabata M; Fujiwara K; Kozuki T; Okada T; Hisamoto A; Tanimoto M
    Lung Cancer; 2004 Nov; 46(2):255-61. PubMed ID: 15474674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib ('Iressa', ZD1839) is active against brain metastases in a 77 year old patient.
    Roggero E; Busi G; Palumbo A; Pedrazzini A
    J Neurooncol; 2005 Feb; 71(3):277-80. PubMed ID: 15735917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastasis responding to gefitinib alone.
    Poon AN; Ho SS; Yeo W; Mok TS
    Oncology; 2004; 67(2):174-8. PubMed ID: 15539923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.
    Shimato S; Mitsudomi T; Kosaka T; Yatabe Y; Wakabayashi T; Mizuno M; Nakahara N; Hatano H; Natsume A; Ishii D; Yoshida J
    Neuro Oncol; 2006 Apr; 8(2):137-44. PubMed ID: 16510849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial.
    Ceresoli GL; Cappuzzo F; Gregorc V; Bartolini S; Crinò L; Villa E
    Ann Oncol; 2004 Jul; 15(7):1042-7. PubMed ID: 15205197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib as a first line of therapy in non-small cell lung cancer with brain metastases.
    Ishida A; Kanoh K; Nishisaka T; Miyazu Y; Iwamoto Y; Kohno N; Miyazawa T
    Intern Med; 2004 Aug; 43(8):718-20. PubMed ID: 15468973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
    Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
    Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
    Omuro AM; Kris MG; Miller VA; Franceschi E; Shah N; Milton DT; Abrey LE
    Cancer; 2005 Jun; 103(11):2344-8. PubMed ID: 15844174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total regression of brain metastases in non-small cell lung cancer patients harboring EGFR mutations treated with gefitinib without radiotherapy: two case reports.
    Chonan M; Narita N; Tominaga T
    BMC Res Notes; 2016 Jan; 9():2. PubMed ID: 26724810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gefitinib and erlotinib for non-small cell lung cancer patients who fail to respond to radiotherapy for brain metastases.
    Song Z; Zhang Y
    J Clin Neurosci; 2014 Apr; 21(4):591-5. PubMed ID: 24256883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases in metastatic non-small cell lung cancer responding to single-agent gefitinib: a case report.
    Stemmler HJ; Weigert O; Krych M; Schoenberg SO; Ostermann H; Hiddemann W
    Anticancer Drugs; 2005 Aug; 16(7):747-9. PubMed ID: 16027524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases.
    Altavilla G; Arrigo C; Santarpia MC; Galletti G; Picone G; Marabello G; Tomasello C; Pitini VV
    J Neurooncol; 2008 Oct; 90(1):31-3. PubMed ID: 18566747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Kashima J; Okuma Y; Miwa M; Hosomi Y
    Med Oncol; 2016 Nov; 33(11):129. PubMed ID: 27757781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity.
    Chiu CH; Tsai CM; Chen YM; Chiang SC; Liou JL; Perng RP
    Lung Cancer; 2005 Jan; 47(1):129-38. PubMed ID: 15603863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib.
    Katz A; Zalewski P
    Br J Cancer; 2003 Dec; 89 Suppl 2(Suppl 2):S15-8. PubMed ID: 14661048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations.
    Yokoyama Y; Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Date H
    Int J Clin Oncol; 2015 Dec; 20(6):1122-9. PubMed ID: 25953679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gefitinib in the treatment of advanced non-small cell lung cancer].
    Yang L; Liu XY; Fang J; An TT; Wu MN
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):474-7. PubMed ID: 17152500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.